Spontaneous Tumor Regression in Tasmanian Devils Associated with RASL11A Activation
Mark J Margres1,2, Manuel Ruiz-Aravena3, Rodrigo Hamede3,4
1School of Biological Sciences, Washington State University, Pullman, Washington 99164 mark_margres@fas.harvard.edu.
Genetics
|June 20, 2020
Summary
A specific gene mutation, RASL11A, drives spontaneous tumor regression in Tasmanian devils. This finding offers insights into cancer mechanisms and potential therapeutic strategies for devil facial tumor disease.
Area of Science:
- Comparative genomics
- Cancer biology
- Evolutionary medicine
Background:
- Spontaneous tumor regression is rare and poorly understood.
- Tasmanian devils face extinction due to a transmissible cancer with high mortality.
- Previous research focused on host genetics, not tumor genetics, for regression.
Purpose of the Study:
- To identify genetic variations within tumors associated with spontaneous regression.
- To investigate the role of specific genes in tumor regression in Tasmanian devils.
Main Methods:
- Comparative and functional genomics were employed.
- Analysis focused on tumor genetic variation.
- Gene expression analysis and in vitro proliferation assays were conducted.
Main Results:
- A single point mutation in the 5' untranslated region of RASL11A was identified as a key factor in tumor regression.
- RASL11A was expressed in regressed tumors but silenced in nonregressed tumors.
- Induced RASL11A expression inhibited tumor cell proliferation in vitro.
Conclusions:
- RASL11A mutation is a significant driver of spontaneous tumor regression in Tasmanian devils.
- RASL11A downregulation is observed in human cancers, suggesting a conserved mechanism.
- RASL11A activation presents a potential therapeutic target for Tasmanian devils and other cancers.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:38The Ras Gene
6.9K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.9K
01:24Small GTPases - Ras and Rho
5.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.0K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.0K